Mesenchymal stem cells (MSCs) show unexplained differences in differentiation potential. In this study, differentiation of human (h) MSCs derived from embryonic, fetal and adult sources toward cardiomyocytes, endothelial and smooth muscle cells was investigated. Labeled hMSCs derived from embryonic stem cells (hESC-MSCs), fetal umbilical cord, bone marrow, amniotic membrane and adult bone marrow and adipose tissue were co-cultured with neonatal rat cardiomyocytes (nrCMCs) or cardiac fibroblasts (nrCFBs) for 10 days, and also cultured under angiogenic conditions. Cardiomyogenesis was assessed by human-specific immunocytological analysis, whole-cell current-clamp recordings, human-specific qRT-PCR and optical mapping. After co-culture with nr...
SummaryCardiomyocytes derived from human embryonic stem cells (hESC-CMs) can improve the contractili...
The concept of tissue-restricted differentiation of postnatal stem cells has been challenged by rece...
It has been proposed the use of resident stem cells (SCs) for the repair of cardiac injuries. Howeve...
Mesenchymal stem cells (MSCs) show unexplained differences in differentiation potential. In this stu...
Mesenchymal stem cells (MSCs) are promising cells for cardiovascular regenerative medicine. However,...
Background—Cardiomyocytes derived from human embryonic stem (hES) cells could be useful in restoring...
Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a range of...
Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced...
Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a range of...
Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced...
<div><p>Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a ...
AbstractBackgroundIntercellular crosstalk and cellular plasticity are key factors in embryogenesis a...
Cardiomyocyte progenitor cells (CMPCs) can be isolated from the human heart and differentiated into ...
The concept of tissue-restricted differentiation of postnatal stem cells has been challenged by rece...
Several adherent postnatal stem cells have been described with different phenotypic and functional p...
SummaryCardiomyocytes derived from human embryonic stem cells (hESC-CMs) can improve the contractili...
The concept of tissue-restricted differentiation of postnatal stem cells has been challenged by rece...
It has been proposed the use of resident stem cells (SCs) for the repair of cardiac injuries. Howeve...
Mesenchymal stem cells (MSCs) show unexplained differences in differentiation potential. In this stu...
Mesenchymal stem cells (MSCs) are promising cells for cardiovascular regenerative medicine. However,...
Background—Cardiomyocytes derived from human embryonic stem (hES) cells could be useful in restoring...
Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a range of...
Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced...
Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a range of...
Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced...
<div><p>Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a ...
AbstractBackgroundIntercellular crosstalk and cellular plasticity are key factors in embryogenesis a...
Cardiomyocyte progenitor cells (CMPCs) can be isolated from the human heart and differentiated into ...
The concept of tissue-restricted differentiation of postnatal stem cells has been challenged by rece...
Several adherent postnatal stem cells have been described with different phenotypic and functional p...
SummaryCardiomyocytes derived from human embryonic stem cells (hESC-CMs) can improve the contractili...
The concept of tissue-restricted differentiation of postnatal stem cells has been challenged by rece...
It has been proposed the use of resident stem cells (SCs) for the repair of cardiac injuries. Howeve...